Skip to product information
1 of 1

FDA LAMISIL NDA 020192 Approval Package — FDA Reviews

FDA LAMISIL NDA 020192 Approval Package — FDA Reviews

Regular price $179.00 USD
Regular price Sale price $179.00 USD
Sale Sold out

This FOIAdocs regulatory document collection brings together FDA approval records for LAMISIL, NDA 020192. The package contains 7 FDA documents totaling 134 pages, organized by original application and supplemental submission.

Research-ready collection with the FDA documents preserved as individual PDFs and organized by regulatory submission.

What's included

  • Original FDA approval records
  • 7 supplemental submissions represented
  • 7 FDA review documents
  • FOIAdocs document index and detailed manifest

Package format: Organized ZIP collection with individual FDA PDFs grouped by regulatory submission, plus a FOIAdocs document index and manifest.

Application: NDA 020192
Product: LAMISIL
Sponsor: NOVARTIS
Documents: 7
Pages: 134
Coverage: Original approval + 7 supplemental submissions represented

View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome